FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LINVENCORVIR
异名/同义词3-((8AS)-7-(((6S)-5-(ETHOXYCARBONYL)-6-(3-FLUORO-2-METHYLPHENYL)-2-(1,3-THIAZOL-2-YL)-1,6-DIHYDROPYRIMIDIN-4-YL)METHYL)-3-OXOHEXAHYDROIMIDAZO(1,5-A)PYRAZIN-2(3H)-YL)-2,2-DIMETHYLPROPANOIC ACID
IMIDAZO(1,5-A)PYRAZINE-2(3H)-PROPANOIC ACID, 7-(((6S)-5-(ETHOXYCARBONYL)-6-(3-FLUORO-2-METHYLPHENYL)-3,6-DIHYDRO-2-(2-THIAZOLYL)-4-PYRIMIDINYL)METHYL)HEXAHYDRO-.ALPHA.,.ALPHA.-DIMETHYL-3-OXO-, (8AS)-
LINVENCORVIR
LINVENCORVIR [INN]
LINVENCORVIR [USAN]
RG7907
RG-7907
RO7049389
RO-7049389
CAS登记号1808248-05-6
物质唯一标识(Unique Ingredient Identifier)74UDO8415O
分子式C29H35FN6O5S
国际化合物标识(International Chemical Identifier,InChI)YLJBFYZGSKMBEZ-MBSDFSHPSA-N
SMILESC(C(CN1C(N2[C@@](CN(CC2)CC3=C([C@@H](N=C(N3)c4sccn4)c5c(c(ccc5)F)C)C(=O)OCC)(C1)[H])=O)(C)C)(=O)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System